Loading...
OTCM
TOBAF
Market cap187kUSD
Dec 05, Last price  
0.03USD
1D
-81.94%
1Q
-70.18%
IPO
-91.00%
Name

TAAT Global Alternatives Inc

Chart & Performance

D1W1MN
OTCM:TOBAF chart
P/E
P/S
0.00
EPS
Div Yield, %
Shrs. gr., 5y
63.15%
Rev. gr., 5y
%
Revenues
95m
+122.45%
0000000000149,452889,77000171,1922,560,72142,535,94494,621,535
Net income
-11m
L-55.36%
-4,021-82,640-78,475-138,756-470,916-105,948-2,203,392-15,807,507-4,020,255-13,650,5832,293,821-1,981,840-6,482,895-519,414-11,200,337-33,508,798-24,904,015-11,116,941
CFO
-1m
L-88.67%
-1,633-43,486-65,680-96,930-243,734-106,092-2,237,364-9,007,923-10,084,107835,247-249,578-1,235,036-1,018,949-1,607,003-3,879,025-20,828,620-9,394,485-1,063,966

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

TAAT Global Alternatives Inc., a life sciences company, develops, manufactures, and distributes non-tobacco based smokable products in Canada and the United States. It offers nicotine-free and tobacco-free alternatives to traditional cigarettes under the TAAT brand. The company was formerly known as TAAT Lifestyle & Wellness Ltd. and changed its name to TAAT Global Alternatives Inc. in April 2021. TAAT Global Alternatives Inc. was incorporated in 2006 and is headquartered in Toronto, Canada.
IPO date
Jun 22, 2020
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑102022‑102021‑102020‑102019‑102018‑102017‑102016‑10
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT